![A Prospective Study of Bevacizumab and Platinum-Based Chemotherapy in NSCLC: Comparison of the Prognostic Value of Early Imaging Response Assessment Criteria and Intratumoral Heterogeneity Analysis]()
A Prospective Study of Bevacizumab and Platinum-Based Chemotherapy in NSCLC: Comparison of the Prognostic Value of Early Imaging Response Assessment Criteria and Intratumoral Heterogeneity AnalysisYip, C.S.; Tacelli, N.; Remy-Jardin, M.; Paul, B.; Cook, G.J.R.; Landau, D.B.; Goh, V. · International Journal of Radiation Oncology*Biology*Physics · 2014